Pacira Pharmaceuticals

PCRX Has Entered Into a Five-Year Agreement with Crosslink Bioscience to Sell EXPAREL
Oct 8, 2013
Pacira Pharmaceuticals (PCRX) has entered into a five-year agreement with US-based orthopedic device distributor CrossLink Bioscience to promote and sell EXPAREL (bupivacaine liposome injectable suspension) for postsurgical pain management ...

Tags: Pacira, Orthopedic Marketplace
Pacira Pharmaceuticals Announced Findings From Two New Studies Supporting Use of Exparel
May 9, 2013
Pacira Pharmaceuticals has announced the findings from two new studies supporting the use of Exparel infiltrated into the transversus abdominis plane for postsurgical pain management Presented at the 2013 Annual Meeting of the ...

Tags: Pacira Pharmaceuticals, Positive Results
EXPAREL Indicated for Administration Into Surgical Site to Produce Postsurgical Analgesia
Nov 29, 2012
Pacira Pharmaceuticals, a specialty pharmaceutical company, has launched EXPAREL (bupivacaine liposome injectable suspension) in the US. EXPAREL is indicated for administration into the surgical site to produce postsurgical analgesia. ...

Tags: pacira pharmaceuticals, EXPAREL